Vanillin Inhibits Matrix Metalloproteinase-9 Expression Through Down-regulation of Nuclear Factor-kappaB Signaling Pathway in Human Hepatocellular Carcinoma Cells
Overview
Pharmacology
Affiliations
Vanillin has been reported to exhibit anti-invasive and antimetastatic activities by suppressing the enzymatic activity of matrix metalloproteinase-9 (MMP-9). However, the underlying mechanism of anti-invasive activity remains unclear so far. Herein we demonstrate that vanillin reduced 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MMP-9 gelatinolytic activity and suppressed cell invasion through the down-regulation of MMP-9 gene transcription in HepG2 cells. Vanillin significantly reduced the 6.6-fold invasive capacity of HepG2 cells in noncytotoxic concentrations, and this anti-invasive effect was concentration-dependent in the Matrigel invasion assay. Moreover, vanillin significantly suppressed the TPA-induced enzymatic activity of MMP-9 and decreased the induced mRNA level of MMP-9. Analysis of the transcriptional regulation indicated that vanillin suppressed MMP-9 transcription by inhibiting nuclear factor-kappaB (NF-kappaB) activity. Western blot further confirmed that vanillin inhibited NF-kappaB activity through the inhibition of IkappaB-alpha phosphorylation and degradation. In conclusion, vanillin might be a potent antiinvasive agent that suppresses the MMP-9 enzymatic activity via NF-kappaB signaling pathway.
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer.
Vesela K, Kejik Z, Masarik M, Babula P, Dytrych P, Martasek P ACS Pharmacol Transl Sci. 2024; 7(11):3394-3418.
PMID: 39539276 PMC: 11555516. DOI: 10.1021/acsptsci.4c00518.
Alaouna M, Hull R, Molefi T, Khanyile R, Mbodi L, Luvhengo T Curr Issues Mol Biol. 2024; 46(10):10806-10828.
PMID: 39451522 PMC: 11506433. DOI: 10.3390/cimb46100642.
Chang H, Chang A, Tsai B, Chen Y, Wu S, Chen L J Cell Mol Med. 2024; 28(17):e70065.
PMID: 39233332 PMC: 11374694. DOI: 10.1111/jcmm.70065.
Jeong J, Kim J, Kim J, Kim C, Ko J, Kim T Nutrients. 2023; 15(2).
PMID: 36678124 PMC: 9867500. DOI: 10.3390/nu15020253.
Pourhadi M, Ghasemi A, Abediny R, Javanmard S, Vaseghi G Adv Biomed Res. 2022; 11:68.
PMID: 36325172 PMC: 9621346. DOI: 10.4103/abr.abr_280_21.